Mounia Azizi, Ali El Khand, Rabiaa Bounabe, A. Sobhi, Y. Zajjari, A. Alayoud, Souhail Mouline
{"title":"Renal Injury During Viral Infections","authors":"Mounia Azizi, Ali El Khand, Rabiaa Bounabe, A. Sobhi, Y. Zajjari, A. Alayoud, Souhail Mouline","doi":"10.36348/sjmps.2024.v10i02.002","DOIUrl":null,"url":null,"abstract":"Renal pathologies following viral infections have become an emerging public health problem in both developed and developing countries. Diagnostic criteria are complex. In most cases, they involve correlation between clinical, biological and histological data, with occasional recourse to molecular biology techniques. Several mechanisms are involved in the pathogenesis of virus-related nephropathy, including virus tropism in the kidney, formation of immune complexes in situ or in the bloodstream, direct cytopathogenic effects, and multiple organ failure. The hepatitis C virus is responsible for three main types of kidney disease: membranoproliferative glomerulnephritis, cryoglobulinemia and membranous nephropathy. Hepatitis B virus is associated with membranous nephropathy, membranoproliferative glomerulnethritis, and IgA nephropathy. HIV (human immunodeficiency virus) infection is associated with several glomerular and tubular kidney damage. HIVAN (HIV-associated nephropathy), a specific entity mainly affecting Africans and African-Americans, presents as a rapidly progressive glomerulonephritis rapidly progressing to the terminal stage. Infections secondary to adenovirus, cytomegalovirus, epstein-barr virus, poliomavirus and coronavirus are often responsible for acute or chronic tubulointerstitial nephritis. Treatment is mainly symptomatic, based on nephroprotection measures, rarely combined with antiviral therapy. Prophylaxis with vacci-nation, when available, remains the best means of preventing viral nephropathy.","PeriodicalId":508857,"journal":{"name":"Saudi Journal of Medical and Pharmaceutical Sciences","volume":"18 11","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Saudi Journal of Medical and Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.36348/sjmps.2024.v10i02.002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Renal pathologies following viral infections have become an emerging public health problem in both developed and developing countries. Diagnostic criteria are complex. In most cases, they involve correlation between clinical, biological and histological data, with occasional recourse to molecular biology techniques. Several mechanisms are involved in the pathogenesis of virus-related nephropathy, including virus tropism in the kidney, formation of immune complexes in situ or in the bloodstream, direct cytopathogenic effects, and multiple organ failure. The hepatitis C virus is responsible for three main types of kidney disease: membranoproliferative glomerulnephritis, cryoglobulinemia and membranous nephropathy. Hepatitis B virus is associated with membranous nephropathy, membranoproliferative glomerulnethritis, and IgA nephropathy. HIV (human immunodeficiency virus) infection is associated with several glomerular and tubular kidney damage. HIVAN (HIV-associated nephropathy), a specific entity mainly affecting Africans and African-Americans, presents as a rapidly progressive glomerulonephritis rapidly progressing to the terminal stage. Infections secondary to adenovirus, cytomegalovirus, epstein-barr virus, poliomavirus and coronavirus are often responsible for acute or chronic tubulointerstitial nephritis. Treatment is mainly symptomatic, based on nephroprotection measures, rarely combined with antiviral therapy. Prophylaxis with vacci-nation, when available, remains the best means of preventing viral nephropathy.
在发达国家和发展中国家,病毒感染引起的肾脏病变已成为一个新出现的公共卫生问题。诊断标准十分复杂。在大多数情况下,它们涉及临床、生物和组织学数据之间的相关性,偶尔也会求助于分子生物学技术。病毒相关肾病的发病机制有多种,包括病毒对肾脏的滋养作用、原位或血液中免疫复合物的形成、直接的细胞致病作用以及多器官功能衰竭。丙型肝炎病毒主要导致三种类型的肾病:膜增生性肾小球肾炎、冷球蛋白血症和膜性肾病。乙型肝炎病毒与膜性肾病、膜增生性肾小球肾炎和 IgA 肾病有关。艾滋病毒(人类免疫缺陷病毒)感染与多种肾小球和肾小管损害有关。HIVAN(艾滋病毒相关性肾病)是一种主要影响非洲人和非裔美国人的特殊疾病,表现为快速进展的肾小球肾炎,并迅速发展到晚期。继发于腺病毒、巨细胞病毒、天疱疮病毒、脊髓灰质炎病毒和冠状病毒的感染通常会导致急性或慢性肾小管间质性肾炎。治疗主要是对症治疗,以肾保护措施为基础,很少与抗病毒治疗相结合。如果有疫苗,使用疫苗预防仍是预防病毒性肾病的最佳方法。